Paragon Private Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$250K Buy
1,981
+16
+0.8% +$2.11K 0.07% 206
2026
Q1
$274K Buy
1,965
+84
+4% +$11.8K 0.09% 192
2025
Q4
$231K Buy
+1,881
New +$229K 0.07% 200

Other funds holding GILD

Paragon Private Wealth Management's GILD Position: Q2 2026 in Review

Paragon Private Wealth Management increased its Gilead Sciences (GILD) stake by 0.81% in Q2 2026, buying an estimated $2.11K and bringing the position to 1,981 shares worth $250K. The position accounts for 0.07% of the portfolio, ranked #206.

Paragon Private Wealth Management first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $274K in Q1 2026. 1,025 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Paragon Private Wealth Management held 1,981 shares of Gilead Sciences worth $250K as of Q2 2026.
  • Paragon Private Wealth Management bought 16 Gilead Sciences shares in Q2 2026, an estimated $2.11K.
  • Gilead Sciences made up 0.07% of Paragon Private Wealth Management's portfolio in Q2 2026, its #206 holding.
  • Paragon Private Wealth Management first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Paragon Private Wealth Management's Gilead Sciences position peaked at $274K in Q1 2026.
  • 1,025 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Paragon Private Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.